Guardant Health (GH) Enterprise Value (2018 - 2026)

Guardant Health has disclosed Enterprise Value across 9 years of filings, most recently posting $19.0 billion for Q2 2026.

• In Q2 2026, Enterprise Value rose 224.73% year-over-year to $19.0 billion; the TTM figure through Jun 2026 stood at $19.0 billion (up 224.73% YoY), while the FY2025 annual figure was $12.1 billion, up 311.85% from the prior year.
• Enterprise Value came in at $19.0 billion for Q2 2026 at Guardant Health, up from $11.0 billion in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $19.0 billion in Q2 2026 to a low of $1.5 billion in Q1 2023.
• Average Enterprise Value over 5 years is $5.2 billion, with a median of $3.1 billion recorded in 2022.
• Year-over-year, Enterprise Value plunged 80.75% in 2022 and jumped 311.85% in 2025.
• Over 5 years, Enterprise Value stood at $1.8 billion in 2022, then climbed by 19.18% to $2.1 billion in 2023, then soared by 38.96% to $2.9 billion in 2024, then soared by 311.85% to $12.1 billion in 2025, then soared by 56.43% to $19.0 billion in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $19.0 billion in Q2 2026, $11.0 billion in Q1 2026, and $12.1 billion in Q4 2025.